ADC Therapeutics SA Contingent Liabilities Incurred By Venturer In Relation To Interests In Joint Ventures
ADC Therapeutics SA (ADCT) had Contingent Liabilities Incurred By Venturer In Relation To Interests In Joint Ventures of $23.54 million as of 2023-09-30, per its 6-K filed 2023-11-07.
Discontinued › Notes
ifrs-full:ContingentLiabilitiesIncurredByVenturerInRelationToInterestsInJointVentures · last filed 2023-11-07
- 2023-09-30: Contingent Liabilities Incurred By Venturer In Relation To Interests In Joint Ventures $23.54M.
- 2023-06-30: Contingent Liabilities Incurred By Venturer In Relation To Interests In Joint Ventures $23.54M.
- 2023-03-31: Contingent Liabilities Incurred By Venturer In Relation To Interests In Joint Ventures $23.54M.
- 2022-12-31: Contingent Liabilities Incurred By Venturer In Relation To Interests In Joint Ventures $23.54M.
| Period end | Contingent Liabilities Incurred By Venturer In Relation To Interests In Joint Ventures |
|---|---|
| 2023-09-30 | $23.54M 6-K · filed 2023-11-07 |
| 2023-06-30 | $23.54M 6-K · filed 2023-08-08 |
| 2023-03-31 | $23.54M 6-K · filed 2023-05-09 |
| 2022-12-31 | $23.54M 6-K · filed 2023-11-07 |
| 2022-09-30 | $23.54M 6-K · filed 2022-11-08 |
| 2022-06-30 | $23.54M 6-K · filed 2022-08-09 |
| 2022-03-31 | $23.54M 6-K · filed 2022-05-09 |
| 2021-12-31 | $23.54M 20-F · filed 2023-03-15 |
| 2021-09-30 | $23.54M 6-K · filed 2021-11-02 |
| 2021-06-30 | $23.54M 6-K · filed 2021-08-03 |
| 2021-03-31 | $23.54M 6-K · filed 2021-05-06 |
| 2020-12-31 | $23.54M 20-F · filed 2022-03-17 |
| 2019-12-31 | $0.00 20-F · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |